Tag: Monsanto shareholder approval
Bayer acquires Monsanto for $66bn
German drug maker Bayer has agreed to purchase US seed giant Monsanto for $66 billion, creating a vast conglomerate spanning pharmaceuticals, health products and...
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
